Tab. I.
Experts’ opinion.
| General comments of expert panel | The following points were shared and appreciated by the panel of experts:
The experts underlined the heterogeneity and complexity of the various clinical conditions that may require catheterization as well as the variability of their clinical-epidemiological burden, especially in Italy. The experts also underlined the importance of greater prevention of UTIs related to IC. The importance of greater patient involvement was emphasized. In Italy, the actions of patient Associations but also of citizens are very strong. With regard to the medical device under study, the potential characteristics and opportunities to enhance patient safety and improve their quality of life should be considered (as reported in: Cittadinanzattiva. Carta della qualità e della sicurezza delle cure per pazienti e operatori sanitari. 2020. Available at: https://www.cittadinanzattiva.it/multimedia/import/files/progetti/salute/CARTA_della_qualit%C3%A0_e_della_sicurezza_delle_cure_per_pazienti_e_operatori_sanitari_1.pdf). Experts have highlighted the need to:
|
| Comments on review of the literature | According to the experts, the literature review was performed correctly from a methodological point of view and was fundamental to highlight the epidemiological gap on the number of patients with IC in Italy as well as on the prevalence of UTIs related to IC. This gap can be filled with further ad hoc studies aimed at producing scientific evidence on this health topic. The epidemiological data on the UTIs burden are heterogeneous in relation to the target population studied, the size of the sample, the study design, the definition of UTIs and the basic disease considered. Studies on the burden of IC-related UTIs in patients with multiple sclerosis and benign prostatic hyperplasia are still limited and more studies are needed to define the clinical-epidemiological burden. However, UTIs are also present in these target populations and underline a health need that must also be taken into account in these patients. |
| Comments on economic model | The members of the Advisory Board believe that the economic assessment presented is consistent. However, they underlined the need to build economic models that evaluate the cost-effectiveness of the different types of available catheters and that take into account the complications avoided (e.g. UTI), even with head-to-head comparisons. Furthermore, it would be useful to build ad hoc models on specific target populations and specific diseases that require catheterization. |
| Final comments | All the experts expressed particular interest in the contents proposed during the meeting, underlining the importance of working and producing evidence in this area in a perspective of value-based healthcare. The problem of IC-related UTIs is a serious problem and, unfortunately, underestimated. It deserves to be evaluated, deepened and disclosed in order to identify real and, where possible, innovative solutions. Finally, the panel expressed particular interest in the proposed study and the pre-assessment of the new technology under study, underlining the importance of the HTA evaluation of medical devices. |